| Literature DB >> 25883748 |
Felix Grases1, Rafel M Prieto1, Rafel A Fernandez-Cabot2, Antonia Costa-Bauzá1, Fernando Tur2, Jose Juan Torres3.
Abstract
Nephrolithiasis is a complex disease that results from a combination of factors related to both urine composition and kidney morphoanatomy. Development of calcium oxalate monohydrate papillary calculi is linked to initial subepithelial calcification of renal papilla. Progressive tissue calcification depends on preexisting injury and involves reactive oxygen species. Many plant extracts that protect against oxidative stress manifest antilithiasic activity. Our study focused on determining the effects of polyphenols on a lithiasis rat model. Rats were pretreated with polyphenols and grape seed extracts, followed by posterior induction of hyperoxalosis via treatment with ethylene glycol plus NH4Cl. The concentrations of calcium and other elements in kidney were determined, along with histological examination of kidney and 24 h urine analysis. Significant differences were observed in the renal calcium content between the control plus ethylene glycol-treated group and the epicatechin plus ethylene glycol-treated, red grape seed extract plus ethylene glycol-treated, and white grape seed extract plus ethylene glycol-treated groups, with reductions of about 50%. The antioxidant activity of polyphenols extracted from red and white grape seeds may be critical in the prevention of calcium oxalate monohydrate papillary calculus formation, particularly if calculi are induced by lesions caused by cytotoxic compounds with oxidative capacity.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25883748 PMCID: PMC4389982 DOI: 10.1155/2015/813737
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Kidney content of calcium, magnesium, and phosphorus.
| Pretreatment | EG treatment | Calcium | Magnesium | Phosphorus |
|---|---|---|---|---|
| (mg/g) | (mg/g) | (mg/g) | ||
| CTR | 0.280 ± 0.005 | 0.302 ± 0.006 | 10.6 ± 0.2 | |
| EPI | 0.284 ± 0.030 | 0.296 ± 0.014 | 10.2 ± 0.4 | |
| RGS | 0.255 ± 0.008a | 0.288 ± 0.004 | 10.1 ± 0.1 | |
| WGS | 0.261 ± 0.012 | 0.295 ± 0.004 | 10.3 ± 0.2 | |
| CTR | EG | 3.951 ± 0.934* | 0.297 ± 0.011 | 10.4 ± 0.1 |
| EPI | EG | 2.274 ± 0.447∗,a | 0.302 ± 0.010 | 9.9 ± 0.4 |
| RGS | EG | 1.734 ± 0.564∗,a | 0.311 ± 0.005* | 10.5 ± 0.1 |
| WGS | EG | 1.979 ± 0.196∗,a | 0.293 ± 0.010 | 9.9 ± 0.3 |
Values represent mean ± SEM of eight animals per group. (CTR): control with no pretreatment, (EPI): epicatechin pretreatment, (RGS): red grape seed extract pretreatment, (WGS): white grape seed extract pretreatment, and (EG): ethylene glycol/NH4Cl treatment.
*Values significantly different to the respective pretreated groups, P < 0.05; avalues significantly different to CTR, P < 0.05.
Histology data from renal papillary tissue (n = 3).
| Pretreatment | EG treatment | Crystal deposits |
|---|---|---|
| CTR | 0 | |
| EPI | 0 | |
| RGS | 0 | |
| WGS | 0 | |
| CTR | EG | +++ |
| EPI | EG | +++ |
| RGS | EG | + |
| WGS | EG | ++ |
(CTR): control with no pretreatment, (EPI): epicatechin pretreatment, (RGS): red grape seed extract pretreatment, (WGS): white grape seed extract pretreatment, and (EG): ethylene glycol/NH4Cl treatment.
0 = no crystallization; + = mild crystallization; ++ = moderate crystallization; and +++ = severe crystallization.
Urinary biochemical data at the end of experiment, following 8 days of ethylene glycol/NH4Cl treatment.
| Pretreatment | EG treatment | Diuresis | Creatinine | pH | Oxalate | Calcium | Magnesium | Phosphorous |
|---|---|---|---|---|---|---|---|---|
| (mL/24 h) | (mg/24 h) | (units) | (mM) | (mM) | (mM) | (mM) | ||
| CTR | 30.7 ± 1.7 | 11.6 ± 0.3 | 7.2 ± 0.1 | 0.21 ± 0.02 | 0.56 ± 0.05 | 0.45 ± 0.05 | 14.20 ± 1.06 | |
| EPI | 24.9 ± 2.1 | 9.3 ± 0.3 | 7.2 ± 0.0 | 0.24 ± 0.02 | 0.50 ± 0.05 | 0.44 ± 0.06 | 15.67 ± 1.31 | |
| RGS | 25.4 ± 0.6 | 9.1 ± 0.3 | 7.3 ± 0.1 | 0.21 ± 0.01 | 0.51 ± 0.02 | 0.47 ± 0.07 | 15.78 ± 0.65 | |
| WGS | 27.8 ± 1.5 | 10.6 ± 0.3 | 7.3 ± 0.1 | 0.23 ± 0.02 | 0.53 ± 0.07 | 0.46 ± 0.06 | 13.17 ± 0.70c | |
| CTR | EG | 9.0 ± 3.5* | 4.0 ± 0.1* | 7.1 ± 0.5 | 1.32 ± 0.13* | 0.29 ± 0.06* | 1.70 ± 0.43* | 50.51 ± 11.11* |
| EPI | EG | 7.8 ± 1.6* | 6.8 ± 0.3a,∗ | 6.3 ± 0.0* | 1.59 ± 0.08* | 0.10 ± 0.03∗,a | 1.51 ± 0.15* | 23.07 ± 2.77∗,a |
| RGS | EG | 12.3 ± 1.6∗,b | 8.2 ± 0.4a | 7.6 ± 0.5b | 2.69 ± 0.63∗,a | 0.08 ± 0.03∗,a | 1.09 ± 0.15∗,b | 34.65 ± 3.15∗,b |
| WGS | EG | 16.0 ± 1.3∗,b | 10.1 ± 0.2a | 6.2 ± 0.1∗,a,c | 2.17 ± 0.12∗,a,b | 0.04 ± 0.01∗,a,b | 1.47 ± 0.28* | 33.87 ± 2.83∗,b |
(CTR): control not pretreated, (EPI): epicatechin pretreated, (RGS): red grape seed extract pretreated, (WSE): white grape seed extract pretreated, and (EG): ethylene glycol/NH4Cl treatment.
Values represent mean ± SEM; *values significantly different to the respective pretreated group, P ≤ 0.05; avalues significantly different to CTR, P ≤ 0.05; bvalues significantly different to EPI, P ≤ 0.05; cvalues significantly different to RGS, P ≤ 0.05.